Rock Creek Pharmaceuticals, Inc. (NASDAQ:STSI)

CAPS Rating: 1 out of 5

The Company is engaged in developing, implementing and licensing scientific technology for the curing of tobacco and also manufactures, markets and develops very low-nitrosamine smokeless tobacco products and selling of discount cigarettes.


Player Avatar EnigmaDude (98.04) Submitted: 11/23/2012 11:44:36 AM : Underperform Start Price: $2.67 STSI Score: +5.95

This is maybe my 8th time picking this scam of a stock to underperform!

Member Avatar EnigmaDude (98.04) Submitted: 11/23/2012 11:45:40 AM
Recs: 0

actually, the 10th time!

Featured Broker Partners